Cytiva and Pall Corporation invest $1.5B in life sciences manufacturing capacity

Cytiva and Pall Corporation, part of Danaher, are investing $1.5 billion over two years to expand manufacturing capacity for biotechnology products at 13 sites globally, including new sites in the US and UK, and plan to hire 2,000 full-time associates.

“Our customers tell us they need access to manufacturing agility, a robust global supply chain and more regional options.”newswire.ca

• 2 sources
• newswire.caCytiva and Pall Corporation investing 1.5 billion USD over two years to meet growing demand for biotechnology solutionsCytivaJul 27, 2021
• newswire.caCytiva and Pall Corporation investing 1.5 billion USD over two years to meet growing demand for biotechnology solutionsCytivaJul 27, 2021

Summarized from public sources; check the original articles before acting on it.